Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2009085200) ANTI-AMYLOID ANTIBODIES AND USES THEREOF
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2009/085200 International Application No.: PCT/US2008/013881
Publication Date: 09.07.2009 International Filing Date: 19.12.2008
IPC:
C07K 16/18 (2006.01) ,A61K 39/395 (2006.01) ,A61P 25/28 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
28
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applicants:
AMGEN INC. [US/US]; One Amgen Center Drive Thousand Oaks, California 91320-1799, US (AllExceptUS)
BIERE-CITRON, Anja Leona [DE/US]; US (UsOnly)
JACOBSEN, Frederick W. [US/US]; US (UsOnly)
WOOD, Stephen J. [US/US]; US (UsOnly)
Inventors:
BIERE-CITRON, Anja Leona; US
JACOBSEN, Frederick W.; US
WOOD, Stephen J.; US
Agent:
STEINBERG, Nisan A.; One Amgen Center Drive Patent Operations, M/S 28-2-C Thousand Oaks, California 91320-1799, US
Priority Data:
61/016,16721.12.2007US
Title (EN) ANTI-AMYLOID ANTIBODIES AND USES THEREOF
(FR) ANTICORPS ANTI-AMYLOÏDE ET UTILISATIONS DE CEUX-CI
Abstract:
(EN) Compositions for treating neurodegenerative or amyloidogenic disorders such as Alzheimer's disease (AD) are provided. More particularly, anti-amyloid-beta antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.
(FR) La présente invention concerne des compositions pour traiter des troubles neurodégénératifs ou amyloïdogéniques tels que la maladie d'Alzheimer (AD). Plus particulièrement, la présente invention concerne des anticorps anti-amyloïde-bêta, des compositions contenant de tels anticorps, des acides nucléiques, vecteurs et cellules hôtes correspondants et des procédés de préparation de tels anticorps.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2235058EP2261254US20110044986CA2709354AU2008343855